Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
about
Transcriptional Targeting in Cancer Gene TherapySuppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter.Adenoviral targeting of gene expression to tumors.A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR.Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironmentActive adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cellsConstruction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels.Current advances in retroviral gene therapy.Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence.Physiological and tissue-specific vectors for treatment of inherited diseases.Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells.Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements.MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFNgamma: an approach for gene therapy.Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector.Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.
P2860
Q24791038-AEA09E0B-9B28-4CAC-9D8C-6D9C96B66283Q33713915-D3E8920C-60C0-4F23-8BE4-6BFDDB2CD2EDQ33862714-3C3BA244-532D-481D-AF72-EA974D98F7C1Q34113282-7F4E3D20-1AE8-461A-B54A-DDC1A6429C5BQ34155138-8E49070A-C273-4049-B2FF-7ADA0E9D2E5BQ34473301-BD737336-85D3-470A-8099-C78545ADBF31Q34748791-1F6C835F-5D24-4475-B70D-B8E5EA36F25EQ34977697-E9CC13D4-A53A-43DE-A591-8EED72D4F12BQ35237554-05B2855A-DF59-4F60-898F-0DB67BD8DA11Q36984452-D6A41BCB-CC3F-4FA8-BDD8-6EFD4B0F276DQ37801839-8C2D35A3-BC1F-4193-9B75-7EB485B7B3ACQ39970232-B6487C58-F51A-43A7-9785-E145058788E3Q40338070-22BE42C1-7FD6-4A9E-B6D6-EC7C1652EE85Q40561045-1D77718E-78DE-4FC8-8D58-4684A53BC1CAQ40590322-24862CF9-ED04-4650-8606-B9372FDD4373Q44168577-505CE14C-E60D-45C8-8FB1-B80E37103FE3Q45880251-10F41E2E-51AF-465D-95BB-C692F03203A2Q45882787-872632B9-FE3D-41CC-A47B-CF965C76F8F4
P2860
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@en
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@nl
type
label
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@en
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@nl
prefLabel
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@en
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@nl
P2093
P2860
P356
P1433
P1476
Increasing endothelial cell sp ...... cytokine-inducible enhancers.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301177
P577
2000-05-01T00:00:00Z
P5875
P6179
1020129622